Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS AND VIEWS

Two types of fibroblast drive arthritis

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Nature 570, 169-170 (2019)

doi: https://doi.org/10.1038/d41586-019-01594-9

References

  1. Lynch, M. D. & Watt, F. M. J. Clin. Invest. 128, 26–35 (2018).

    PubMed  Article  Google Scholar 

  2. Malmström, V., Catrina, A. I. & Klareskog, L. Nature Rev. Immunol. 17, 60–75 (2017).

    PubMed  Article  Google Scholar 

  3. Croft, A. P. et al. Nature 570, 246–251 (2019).

    Article  Google Scholar 

  4. Huelsken, J. & Hanahan, D. Cell 172, 643–644 (2018).

    Article  Google Scholar 

  5. Roberts, E. W. et al. J. Exp. Med. 210, 1137–1151 (2013).

    PubMed  Article  Google Scholar 

  6. Vallejos, C. A., Risso, D., Scialdone, A., Dudoit, S. & Marioni, J. C. Nature Methods 14, 565–571 (2017).

    PubMed  Article  Google Scholar 

  7. Vannella, K. M. & Wynn, T. A. Annu. Rev. Physiol. 79, 593–617 (2017).

    PubMed  Article  Google Scholar 

  8. Loeser, R. F., Goldring, S. R., Scanzello, C. R. & Goldring, M. B. Arthritis Rheum. 64, 1697–1707 (2012).

    PubMed  Article  Google Scholar 

Download references

Competing Interests

T.A.W.’s employer Pfizer has approved products for rheumatoid arthritis.

Subjects

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links